Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 149

1.

Preserved wake-dependent cortical excitability dynamics predict cognitive fitness beyond age-related brain alterations.

Van Egroo M, Narbutas J, Chylinski D, Villar González P, Ghaemmaghami P, Muto V, Schmidt C, Gaggioni G, Besson G, Pépin X, Tezel E, Marzoli D, Le Goff C, Cavalier E, Luxen A, Salmon E, Maquet P, Bahri MA, Phillips C, Bastin C, Collette F, Vandewalle G.

Commun Biol. 2019 Dec 3;2(1):449. doi: 10.1038/s42003-019-0693-y.

PMID:
31925338
2.

Preserved wake-dependent cortical excitability dynamics predict cognitive fitness beyond age-related brain alterations.

Van Egroo M, Narbutas J, Chylinski D, Villar González P, Ghaemmaghami P, Muto V, Schmidt C, Gaggioni G, Besson G, Pépin X, Tezel E, Marzoli D, Le Goff C, Cavalier E, Luxen A, Salmon E, Maquet P, Bahri MA, Phillips C, Bastin C, Collette F, Vandewalle G.

Commun Biol. 2019 Dec 3;2:449. doi: 10.1038/s42003-019-0693-y. eCollection 2019.

3.

Progress in Difluoroalkylation of Organic Substrates by Visible Light Photoredox Catalysis.

Lemos A, Lemaire C, Luxen A.

Adv Synth Catal. 2019 Apr 1;361(7):1500-1537. doi: 10.1002/adsc.201801121. Epub 2019 Jan 17. Review.

4.

Cognitive efficiency in late midlife is linked to lifestyle characteristics and allostatic load.

Narbutas J, Egroo MV, Chylinski D, González PV, Jimenez CG, Besson G, Ghaemmaghami P, Hammad G, Muto V, Schmidt C, Luxen A, Salmon E, Maquet P, Bastin C, Vandewalle G, Collette F.

Aging (Albany NY). 2019 Sep 8;11(17):7169-7186. doi: 10.18632/aging.102243. Epub 2019 Sep 8.

5.

In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography.

Bastin C, Bahri MA, Meyer F, Manard M, Delhaye E, Plenevaux A, Becker G, Seret A, Mella C, Giacomelli F, Degueldre C, Balteau E, Luxen A, Salmon E.

Eur J Nucl Med Mol Imaging. 2019 Aug 29. doi: 10.1007/s00259-019-04461-x. [Epub ahead of print]

PMID:
31468182
6.

Late-Stage 18 F-Difluoromethyl Labeling of N-Heteroaromatics with High Molar Activity for PET Imaging.

Trump L, Lemos A, Lallemand B, Pasau P, Mercier J, Lemaire C, Luxen A, Genicot C.

Angew Chem Int Ed Engl. 2019 Sep 9;58(37):13149-13154. doi: 10.1002/anie.201907488. Epub 2019 Aug 9. Review.

7.

A Switchable Domino Process for the Construction of Novel CO2 -Sourced Sulfur-Containing Building Blocks and Polymers.

Ouhib F, Grignard B, Van Den Broeck E, Luxen A, Robeyns K, Van Speybroeck V, Jerome C, Detrembleur C.

Angew Chem Int Ed Engl. 2019 Aug 19;58(34):11768-11773. doi: 10.1002/anie.201905969. Epub 2019 Jul 18.

PMID:
31216118
8.

Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET.

Serrano ME, Becker G, Bahri MA, Seret A, Mestdagh N, Mercier J, Mievis F, Giacomelli F, Lemaire C, Salmon E, Luxen A, Plenevaux A.

Molecules. 2019 May 1;24(9). pii: E1705. doi: 10.3390/molecules24091705.

9.

Fully Automated Synthesis and Evaluation of [18 F]BPAM121: Potential of an AMPA Receptor Positive Allosteric Modulator as PET Radiotracer.

Manos-Turvey A, Becker G, Francotte P, Serrano ME, Luxen A, Pirotte B, Plenevaux A, Lemaire C.

ChemMedChem. 2019 Apr 3;14(7):788-795. doi: 10.1002/cmdc.201800816. Epub 2019 Feb 22.

PMID:
30740927
10.

Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value.

Serrano ME, Bahri MA, Becker G, Seret A, Mievis F, Giacomelli F, Lemaire C, Salmon E, Luxen A, Plenevaux A.

Mol Imaging Biol. 2019 Oct;21(5):888-897. doi: 10.1007/s11307-018-1301-0.

PMID:
30460626
11.

Progress in Lanthionine and Protected Lanthionine Synthesis.

Denoël T, Lemaire C, Luxen A.

Chemistry. 2018 Oct 17;24(58):15421-15441. doi: 10.1002/chem.201801115. Epub 2018 Aug 2. Review.

PMID:
29714402
12.

Human fronto-parietal response scattering subserves vigilance at night.

Gaggioni G, Ly JQM, Chellappa SL, Coppieters 't Wallant D, Rosanova M, Sarasso S, Luxen A, Salmon E, Middleton B, Massimini M, Schmidt C, Casali A, Phillips C, Vandewalle G.

Neuroimage. 2018 Jul 15;175:354-364. doi: 10.1016/j.neuroimage.2018.03.055. Epub 2018 Mar 28.

PMID:
29604455
13.

"NOTA-PRGD2 and NODAGA-PRGD2 : Bioconjugation, characterization, radiolabelling, and design space".

Salvé M, Avohou HT, Monbaliu JM, Lebrun P, Lemaire C, Damblon C, de Tullio P, Hubert P, Hustinx R, Luxen A.

J Labelled Comp Radiopharm. 2018 May 30;61(6):487-500. doi: 10.1002/jlcr.3613. Epub 2018 Apr 25.

PMID:
29430693
14.

Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H.

Bahri MA, Plenevaux A, Aerts J, Bastin C, Becker G, Mercier J, Valade A, Buchanan T, Mestdagh N, Ledoux D, Seret A, Luxen A, Salmon E.

Alzheimers Dement (N Y). 2017 Aug 30;3(4):481-486. doi: 10.1016/j.trci.2017.08.004. eCollection 2017 Nov.

15.

Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors.

Goux M, Becker G, Gorré H, Dammicco S, Desselle A, Egrise D, Leroi N, Lallemand F, Bahri MA, Doumont G, Plenevaux A, Cinier M, Luxen A.

Bioconjug Chem. 2017 Sep 20;28(9):2361-2371. doi: 10.1021/acs.bioconjchem.7b00374. Epub 2017 Sep 12.

PMID:
28825794
16.

Pharmacokinetic Characterization of [18F]UCB-H PET Radiopharmaceutical in the Rat Brain.

Becker G, Warnier C, Serrano ME, Bahri MA, Mercier J, Lemaire C, Salmon E, Luxen A, Plenevaux A.

Mol Pharm. 2017 Aug 7;14(8):2719-2725. doi: 10.1021/acs.molpharmaceut.7b00235. Epub 2017 Jul 13.

PMID:
28651055
17.

Regiospecific radiolabelling of Nanofitin on Ni magnetic beads with [18F]FBEM and in vivo PET studies.

Dammicco S, Goux M, Lemaire C, Becker G, Bahri MA, Plenevaux A, Cinier M, Luxen A.

Nucl Med Biol. 2017 Aug;51:33-39. doi: 10.1016/j.nucmedbio.2017.04.006. Epub 2017 Apr 27.

PMID:
28575696
18.

Comparative assessment of 6-[18 F]fluoro-L-m-tyrosine and 6-[18 F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson's disease rat model.

Becker G, Bahri MA, Michel A, Hustadt F, Garraux G, Luxen A, Lemaire C, Plenevaux A.

J Neurochem. 2017 May;141(4):626-635. doi: 10.1111/jnc.14016. Epub 2017 Apr 12.

19.

Cerebral Activity Associated with Transient Sleep-Facilitated Reduction in Motor Memory Vulnerability to Interference.

Albouy G, King BR, Schmidt C, Desseilles M, Dang-Vu TT, Balteau E, Phillips C, Degueldre C, Orban P, Benali H, Peigneux P, Luxen A, Karni A, Doyon J, Maquet P, Korman M.

Sci Rep. 2016 Oct 11;6:34948. doi: 10.1038/srep34948.

20.

Circadian dynamics in measures of cortical excitation and inhibition balance.

Chellappa SL, Gaggioni G, Ly JQ, Papachilleos S, Borsu C, Brzozowski A, Rosanova M, Sarasso S, Luxen A, Middleton B, Archer SN, Dijk DJ, Massimini M, Maquet P, Phillips C, Moran RJ, Vandewalle G.

Sci Rep. 2016 Sep 21;6:33661. doi: 10.1038/srep33661.

Supplemental Content

Loading ...
Support Center